Compare
Amgen vs TG Therapeutics (AMGN vs TGTX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amgen (AMGN) returned +43.9% and TG Therapeutics (TGTX) +75.8%; so far this year the figures are +40.7% and +100.7%.
Amgen is the larger company by market value, about 27.2 times the size of TG Therapeutics.
On trailing earnings, AMGN trades at 26.7 times and TGTX at 21.8 times.
Revenue grew +8.2% at AMGN and +76.1% at TGTX over the last year.
AMGN yields 2.16%. TGTX pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| AMGN | TGTX | |
|---|---|---|
| Price | $460.42 | $59.83 |
| 1-day | +0.03% | +3.18% |
| YTD | +40.67% | +100.69% |
| 1 year | +43.94% | +75.75% |
| 3 years | +76.51% | +491.16% |
| Market cap | $249.1B | $9.2B |
| P/E | 26.7 | 21.8 |
| P/S | 6.40 | 11.45 |
| P/B | 17.35 | 15.16 |
| Revenue growth | +8.20% | +76.10% |
| EPS growth | +33.30% | +643.20% |
| Gross margin % | 70.9 | 82.4 |
| Net margin % | 24.1 | 55.2 |
| ROE % | 65.4 | 73.1 |
| Debt / equity | 3.76 | 1.23 |
| FCF yield % | 3.8 | 0.2 |
| Dividend yield % | 2.16 | — |
| Beta | 0.50 | 0.56 |
| RSI (14) | 60.5 | 58.7 |
| Technical rating |